Received: from mail-vi1eur03on2075.outbound.protection.outlook.com (HELO EUR03-VI1-obe.outbound.protection.outlook.com) ([40.107.103.75])
  by mta.sm.ee with ESMTP/TLS/ECDHE-RSA-AES256-GCM-SHA384; 13 Mar 2025 12:13:40 +0200
Received: from mta2.sm.ee (10.11.26.144) by TEHIK-EX02.sotsiaalministeerium.ee
 (10.11.26.102) with Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_128_GCM_SHA256) id 15.1.2507.44 via Frontend
 Transport; Thu, 13 Mar 2025 12:14:06 +0200
Received: from AM0P195MB0532.EURP195.PROD.OUTLOOK.COM
 ([fe80::ca72:1d46:39a2:4fd5]) by AM0P195MB0532.EURP195.PROD.OUTLOOK.COM
 ([fe80::ca72:1d46:39a2:4fd5%6]) with mapi id 15.20.8511.026; Thu, 13 Mar 2025
 10:13:33 +0000
Received: from AM0P195MB0532.EURP195.PROD.OUTLOOK.COM (2603:10a6:20b:161::9)
 by DB9P195MB2085.EURP195.PROD.OUTLOOK.COM (2603:10a6:10:3c5::16) with
 Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.8534.25; Thu, 13 Mar
 2025 10:13:33 +0000
Received: from TEHIK-EX02.sotsiaalministeerium.ee (10.11.26.102) by
 TEHIK-EX02.sotsiaalministeerium.ee (10.11.26.102) with Microsoft SMTP Server
 (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_128_GCM_SHA256) id
 15.1.2507.44; Thu, 13 Mar 2025 12:14:06 +0200
Received: from TEHIK-EX02.sotsiaalministeerium.ee (10.11.26.102) by
 TEHIK-EX02.sotsiaalministeerium.ee (10.11.26.102) with Microsoft SMTP Server
 (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_128_GCM_SHA256) id
 15.1.2507.44 via Mailbox Transport; Thu, 13 Mar 2025 12:14:07 +0200
From: "EVD Admin" <EVD.Admin@ecdc.europa.eu>
To: "mateusz.markowicz" <mateusz.markowicz@ages.at>,
	"stephan.aberle" <stephan.aberle@meduniwien.ac.at>,
	"tinne.lernout" <tinne.lernout@sciensano.be>,
	"Javiera Rebolledo" <Javiera.rebolledoromero@sciensano.be>,
	"elica.panayotova" <elica.panayotova@gmail.com>,
	"iva_trrifonova" <iva_trrifonova@abv.bg>,
	"mikov" <mikov@ncipd.org>,
	"zvjezdana.lovric" <zvjezdana.lovric@hzjz.hr>,
	"iva.pem-novosel" <iva.pem-novosel@hzjz.hr>,
	"aaristodimou" <aaristodimou@mphs.moh.gov.cy>,
	"Valentinos Silvestros" <vsilvestros@ns.moh.gov.cy>,
	"m.mendris" <m.mendris@shso.org.cy>,
	"mviolaris" <mviolaris@mphs.moh.gov.cy>,
	=?UTF-8?Q?Hana_Orl=C3=ADkov=C3=A1?= <hana.orlikova@szu.cz>,
	"hana.zelena" <hana.zelena@zuova.cz>,
	"Lasse Skafte Vestergaard" <lav@ssi.dk>,
	"pvb" <pvb@ssi.dk>,
	"Juta Varjas" <juta.varjas@terviseamet.ee>,
	"Maria Vikentjeva" <maria.vikentjeva@terviseamet.ee>,
	"Erika Lindh" <erika.lindh@thl.fi>,
	"Liina Voutilainen" <liina.voutilainen@thl.fi>,
	"Marie-Claire PATY" <marie-claire.paty@santepubliquefrance.fr>,
	"Henriette de Valk" <Henriette.DEVALK@santepubliquefrance.fr>,
	"frankc" <frankc@rki.de>,
	"WilkingH" <WilkingH@rki.de>,
	"Danai Pervanidou" <d.pervanidou@eody.gov.gr>,
	"molnar.zsuzsanna" <molnar.zsuzsanna@nngyk.gov.hu>,
	<nagy.orsolya@nngyk.gov.hu>,
	=?UTF-8?Q?Anna_Margr=C3=A9t_Gu=C3=B0mundsd=C3=B3ttir_-_La?=
	=?UTF-8?Q?ndl?= <anna.m.gudmundsdottir@landlaeknir.is>,
	=?UTF-8?Q?Kamilla_Sigr=C3=AD=C3=B0ur_J=C3=B3sefsd=C3=B3ttir_-_?=
	=?UTF-8?Q?Landl?= <kamilla@landlaeknir.is>,
	"Paul.McKeown" <Paul.McKeown@hpsc.ie>,
	"Patricia Garvey" <patricia.garvey@hpsc.ie>,
	"aoife.colgan" <aoife.colgan@hpsc.ie>,
	"Riccardo Flavia" <flavia.riccardo@iss.it>,
	"Ferraro Federica" <fe.ferraro@sanita.it>,
	"Antra Bormane" <antra.bormane@spkc.gov.lv>,
	"Visscher Carla" <carla.visscher@llv.li>,
	"Walser-Domjan Esther" <Esther.Walser-Domjan@llv.li>,
	=?UTF-8?Q?Galina_Zagrebnevien=C4=97?= <galina.zagrebneviene@sam.lt>,
	"milda.zygutiene" <milda.zygutiene@nvsc.lt>,
	"Jelena Razmuk" <jelena.razmuk@nvspl.lt>,
	"Melillo Tanya at Health Regulation" <tanya.melillo@gov.mt>,
	"Borg Maria-Louise at Health Regulation" <maria-louise.borg@gov.mt>,
	"Chantal Reusken" <chantal.reusken@rivm.nl>,
	"Eelco Franz" <eelco.franz@rivm.nl>,
	"Elisabeth Astrup" <elisabeth.astrup@fhi.no>,
	"Johansen, Tone Kristin Bjordal" <Tone.Johansen@fhi.no>,
	=?UTF-8?Q?Sadkowska-Todys_Ma=C5=82gorzata?= <mtodys@pzh.gov.pl>,
	"Carolina Isabel Bernardes Torres" <citorres@arscentro.min-saude.pt>,
	"Paula Vasconcelos" <pvasconcelos@dgs.min-saude.pt>,
	"Anca Sirbu" <anca.sirbu@insp.gov.ro>,
	"jana.kerlik" <jana.kerlik@vzbb.sk>,
	"edita.staronova" <edita.staronova@uvzsr.sk>,
	"elena.ticha" <elena.ticha@uvzsr.sk>,
	"maja.socan" <maja.socan@nijz.si>,
	"eva.grilc" <eva.grilc@nijz.si>,
	=?UTF-8?Q?Sierra_Moros._Mar=C3=ADa_Jos=C3=A9?= <jsierra@sanidad.gob.es>,
	=?UTF-8?Q?Paz_S=C3=A1nchez-Seco?= <paz.sanchez@isciii.es>,
	"anette.richardson" <anette.richardson@folkhalsomyndigheten.se>,
	<Alma.Brolund@Folkhalsomyndigheten.se>,
	"Zasada Aleksandra A." <azasada@pzh.gov.pl>,
	=?UTF-8?Q?Ana_V=C3=A1zquez_Gonz=C3=A1lez?= <a.vazquez@isciii.es>,
	"NitscheA" <NitscheA@rki.de>,
	"cotar.ioana" <cotar.ioana@cantacuzino.ro>,
	<nagy.anna@nngyk.gov.hu>,
	"annetta.zintl" <annetta.zintl@ucd.ie>,
	"Avgoustinos Stephanou" <avstephanou@mphs.moh.gov.cy>,
	"bettie.voordouw" <bettie.voordouw@rivm.nl>,
	"Borislava Tsafarova" <b.tsafarova@ncipd.org>,
	=?UTF-8?Q?Bronislava_Vichov=C3=A1?= <vichova@saske.sk>,
	=?UTF-8?Q?Brynja_=C3=81rmannsd=C3=B3ttir?= <brynjaa@landspitali.is>,
	"Charalambos Beltsos" <c.beltsos@shso.gov.cy>,
	"Charlotte.Sohier" <charlotte.sohier@sciensano.be>,
	"Christiana Antoniou" <chantoniou@mphs.moh.gov.cy>,
	"ckaragiannis" <ckaragiannis@mphs.moh.gov.cy>,
	"Daan Notermans" <daan.notermans@rivm.nl>,
	"Korhonen, Essi M" <essi.m.korhonen@helsinki.fi>,
	<balla.eszter@nngyk.gov.hu>,
	"fmontarsi" <fmontarsi@izsvenezie.it>,
	"Francesco Severini" <francesco.severini@iss.it>,
	=?UTF-8?Q?Gabija_Tamoli=C5=ABnait=C4=97?= <gabija.tamoliunaite@nvspl.lt>,
	"Gerhard Dobler" <GerhardDobler@bundeswehr.org>,
	"Bongiorno Gioia" <gioia.bongiorno@iss.it>,
	"Guillaume.Fournier" <Guillaume.Fournier@lns.etat.lu>,
	"harry.vennema" <harry.vennema@rivm.nl>,
	"Helena Cortes Martins" <Helena.Cortes-Martins@insa.min-saude.pt>,
	"Helena Jirincova" <helena.jirincova@szu.cz>,
	"Helge.Kampen" <Helge.Kampen@fli.de>,
	=?UTF-8?Q?Hugo_Os=C3=B3rio?= <hugo.osorio@insa.min-saude.pt>,
	"Irena Tabain" <irena.tabain@hzjz.hr>,
	"Irina Odintsova" <irina.odintsova@terviseamet.ee>,
	<isra.deblauwe@gmail.com>,
	"Iva Christova" <iva_christova@ncipd.org>,
	=?UTF-8?Q?Ivana_Zicklerov=C3=A1?= <ivana.zicklerova@bulovka.cz>,
	"RICHTER Jan" <richter@cing.ac.cy>,
	<sztikler.janos@nngyk.gov.hu>,
	=?UTF-8?B?VmXEjWXFmW92w6EgSmFyb23DrXJh?= <jaromira.vecerova@szu.cz>,
	"Jekaterina Jutkina" <jekaterina.jutkina@terviseamet.ee>,
	=?UTF-8?Q?Jekaterina_Ovt=C5=A1innikova?= <jekaterina.ovtsinnikova@terviseamet.ee>,
	"johan.reimerink" <johan.reimerink@rivm.nl>,
	"Johanna Kristina Tamm" <johanna.kristina.tamm@terviseamet.ee>,
	"schmidt-chanasit" <schmidt-chanasit@bnitm.de>,
	<Joerg.Hofmann@laborberlin.com>,
	"Jorge Machado" <Jorge.machado@insa.min-saude.pt>,
	"Jorrit Hofstra" <jorrit.hofstra@rivm.nl>,
	=?UTF-8?Q?Judit_Henczk=C3=B3?= <henczko.judit@nngyk.gov.hu>,
	"Karen Kerkhof" <karen.kerkhof@rivm.nl>,
	"Bakran-Lebl Karin" <karin.bakran-lebl@ages.at>,
	=?UTF-8?Q?Loziakov=C3=A1_Pe=C5=88azziov=C3=A1_Katar=C3=ADna=2C_M?=
	=?UTF-8?Q?gr.=2C_PhD.?= <katarina.penazziova@uvlf.sk>,
	"Pancer Katarzyna" <kpancer@pzh.gov.pl>,
	"katerina.kybicova" <katerina.kybicova@szu.cz>,
	"Katja Adam" <katja.adam@famnit.upr.si>,
	"Kirsi Liitsola" <kirsi.liitsola@thl.fi>,
	=?UTF-8?B?S2zDoXJhIEJyZMOtxI1rb3bDoQ==?= <klara.brdickova@bulovka.cz>,
	"Linda Suurmets" <linda.suurmets@terviseamet.ee>,
	"Liviu Prioteasa" <florianliviu@yahoo.com>,
	"Culverwell, C Lorna" <lorna.culverwell@helsinki.fi>,
	"Toma Luciano" <luciano.toma@iss.it>,
	"Marcella.Mori" <marcella.mori@sciensano.be>,
	"Di Luca Marco" <marco.diluca@iss.it>,
	"Maren Lanzl" <maren.lanzl@rivm.nl>,
	"Mari Steinert" <Mari.Steinert@fhi.no>,
	"m.goffredo" <m.goffredo@izs.it>,
	"marieta.braks" <marieta.braks@rivm.nl>,
	"mvesbroeck" <mvesbroeck@itg.be>,
	"eickmann" <eickmann@staff.uni-marburg.de>,
	"Marlen Timm" <marlen.timm@terviseamet.ee>,
	"Marloes Grobben" <marloes.grobben@rivm.nl>,
	"Martin Kulma" <martin.kulma@szu.cz>,
	=?UTF-8?Q?Korva=2C_Mi=C5=A1a?= <Misa.Korva@mf.uni-lj.si>,
	"Nadia Mitkova" <mit_nadja@abv.bg>,
	"nkalvat" <nkalvat@yahoo.com>,
	=?UTF-8?Q?Pamela_=C3=96sterlund?= <pamela.osterlund@thl.fi>,
	"Panayiota Hadjikyprianou" <ghadjikyprianou@mphs.moh.gov.cy>,
	"Petia Genova" <petia.d.genova@abv.bg>,
	"radomira.limberkova" <radomira.limberkova@szu.cz>,
	"Raluca Gatej" <raluca.gatej@insp.gov.ro>,
	=?UTF-8?B?UmVuw6kgQsO4ZGtlcg==?= <rebo@sund.ku.dk>,
	"lovinrodicadiana" <lovinrodicadiana@yahoo.com>,
	"Salmenlinna Saara" <saara.salmenlinna@thl.fi>,
	"selma.bosnjak" <selma.bosnjak@hzjz.hr>,
	"solvita.selderina" <solvita.selderina@aslimnica.lv>,
	=?UTF-8?Q?So=C5=88a_Feikov=C3=A1?= <feikova@vzbb.sk>,
	"stefka.krumova" <stefka.krumova@gmail.com>,
	"Stephan Becker" <becker@staff.uni-marburg.de>,
	<guenther@bni.uni-hamburg.de>,
	<sreter.tamas@nngyk.gov.hu>,
	"Tatjana.Avsic" <Tatjana.Avsic@mf.uni-lj.si>,
	"tatjana.vilibic-cavlek" <tatjana.vilibic-cavlek@hzjz.hr>,
	"Thomas Roodsant" <thomas.roodsant@rivm.nl>,
	"Urmas Liivas" <urmas.liivas@terviseamet.ee>,
	"vchristodoulou" <vchristodoulou@vs.moa.gov.cy>,
	=?UTF-8?B?VmlrdMOzcmlhIMSMYWJhbm92w6E=?= <viktoria.cabanova@savba.sk>,
	"vladimir.ivovic" <vladimir.ivovic@famnit.upr.si>,
	"wrastawicki" <wrastawicki@pzh.gov.pl>,
	=?UTF-8?Q?Zolt=C3=A1n_Kis?= <kis.zoltan@nngyk.gov.hu>,
	<kienle.zsuzsa@nngyk.gov.hu>
Cc: "EVD Admin" <EVD.Admin@ecdc.europa.eu>,
	"NC_CCB_Austria" <NC_CCB_Austria@bmg.gv.at>,
	"sigrid.kiermayr" <sigrid.kiermayr@gesundheitsministerium.gv.at>,
	"koen.blot" <koen.blot@sciensano.be>,
	<ccb@sciensano.be>,
	"Julien Sohier" <julien.sohier@sciensano.be>,
	"Zhivka Getsova" <getsova@ncipd.org>,
	"Iva Christova" <iva_christova@ncipd.org>,
	"kcapak" <kcapak@hzjz.hr>,
	"bernard.kaic" <bernard.kaic@hzjz.hr>,
	"Elisavet Constantinou" <Econstantinou@moh.gov.cy>,
	"Czech Republic Generic Email Box -" <ECDC_NIPH@szu.cz>,
	=?UTF-8?Q?Hana_Orl=C3=ADkov=C3=A1?= <hana.orlikova@szu.cz>,
	=?UTF-8?Q?Kamilla_Gr=C3=B8nborg_Laut?= <kgrl@sst.dk>,
	"Stine Ulendorf Jacobsen" <Suja@sst.dk>,
	=?UTF-8?B?S8OkcnQgU8O1YmVy?= <kart.sober@terviseamet.ee>,
	"Julia Geller" <julia.geller@terviseamet.ee>,
	"Estonia Generic Email Box -" <info@terviseamet.ee>,
	"Otto Helve" <otto.helve@thl.fi>,
	"Savolainen-Kopra Carita" <carita.savolainen-kopra@thl.fi>,
	"Paula GARCIA-LOBATO" <Paula.garcia-lobato@santepubliquefrance.fr>,
	"Anne-Catherine VISO" <anne-catherine.viso@santepubliquefrance.fr>,
	"Rathmachers, Lea" <RathmachersL@rki.de>,
	"Germany Generic Email Box -" <ecdc@rki.de>,
	"Rexroth, Ute" <RexrothU@rki.de>,
	"Theodora Kalomama" <t.kalomama@eody.gov.gr>,
	"Dimitrios Paraskevis" <d.paraskevis@eody.gov.gr>,
	"Christakis Chatzichristodoulou" <ch.chatzichristodoulou@eody.gov.gr>,
	"Agnes Danielisz" <danielisz.agnes@nngyk.gov.hu>,
	=?UTF-8?Q?Cec=C3=ADlia_M=C3=BCller?= <phc.office@nngyk.gov.hu>,
	=?UTF-8?Q?Judit_Rezs=C5=91fi?= <rezsofi.judit@nngyk.gov.hu>,
	=?UTF-8?Q?Gu=C3=B0r=C3=BAn_Aspelund_-_Landl?= <gudrun.aspelund@landlaeknir.is>,
	"Lois O'Connor" <lois.oconnor@hpsc.ie>,
	"Aine Grace" <aine.grace@hpsc.ie>,
	"Patricia Garvey" <patricia.garvey@hpsc.ie>,
	"Louise Cullen" <louise.cullen@hpsc.ie>,
	"Lisa Domegan" <LisaDomegan@hpsc.ie>,
	"Maraglino Francesco Paolo" <f.maraglino@sanita.it>,
	"Antra Bormane" <antra.bormane@spkc.gov.lv>,
	"Dehler Silvia, Dr. med." <silvia.dehler@llv.li>,
	=?UTF-8?Q?Nerija_Kuprevi=C4=8Dien=C4=97?= <nerija.kupreviciene@sam.lt>,
	=?UTF-8?Q?Jurgita_Pakalni=C5=A1kien=C4=97?= <jurgita.pakalniskiene@sam.lt>,
	"Jean-Claude Schmit" <jean-claude.schmit@ms.etat.lu>,
	"Gauci Charmaine at Health Regulation" <charmaine.gauci@gov.mt>,
	"Hester de Melker" <Hester.de.Melker@rivm.nl>,
	"Susan van den Hof" <Susan.van.den.Hof@RIVM.NL>,
	"Macdonald, Emily Ann" <EmilyAnn.MacDonald@fhi.no>,
	"Heidi Lange" <heidi.lange@fhi.no>,
	"Zacharczuk Katarzyna" <kzacharczuk@pzh.gov.pl>,
	"Mariana Ferreira" <marianaferreira@dgs.min-saude.pt>,
	"Pedro Licinio Pinto Leite" <pedroleite@dgs.min-saude.pt>,
	<cesp@dgs.min-saude.pt>,
	=?UTF-8?Q?Andr=C3=A9_Peralta_Santos?= <aperaltasantos@dgs.min-saude.pt>,
	"Adriana Pistol" <adriana.pistol@ms.ro>,
	"lucia.paulikova" <lucia.paulikova@uvzsr.sk>,
	"ecdc" <ecdc@uvzsr.sk>,
	"maja.socan" <maja.socan@nijz.si>,
	"Slovenia Generic Email Box -" <ecdcinfo@nijz.si>,
	=?UTF-8?Q?Sierra_Moros._Mar=C3=ADa_Jos=C3=A9?= <jsierra@sanidad.gob.es>,
	=?UTF-8?Q?Sim=C3=B3n_Soria._Fernando?= <fsimon@sanidad.gob.es>,
	"Sweden Generic Email Box -" <ecdc.sweden@folkhalsomyndigheten.se>,
	"Sweden Generic Email Support -" <ecdc.support@folkhalsomyndigheten.se>,
	"Agneta Falk Filipsson" <agneta.falkfilipsson@folkhalsomyndigheten.se>,
	"Sara Bengtsson" <Sara.bengtsson@folkhalsomyndigheten.se>,
	"birgitta.lesko" <birgitta.lesko@folkhalsomyndigheten.se>,
	"anette.richardson" <anette.richardson@folkhalsomyndigheten.se>
Subject: ECDC webpages on travel-associated cases of malaria, dengue, chikungunya, and Zika virus disease
Date: Thu, 13 Mar 2025 12:13:32 +0200
Message-ID: <AM0P195MB0532698770D8392F685D86E1C1D32@AM0P195MB0532.EURP195.PROD.OUTLOOK.COM>
MIME-Version: 1.0
Content-Type: multipart/alternative;
	boundary="----=_NextPart_000_00D8_01DB9413.EB509D60"
X-Mailer: Microsoft Outlook 16.0
Thread-Index: AQKiyh+uuuCXKnIE8IJOw0seMlMb2Q==
Content-Language: en-us
X-OlkEid: 0000000037403B17262C2548A1238A6CC2B5FA7E070034AD76187591974DBF6C4F76951C873A0100020000000000F388CE40D9F9A64186131351AA13751900000000141200009D02A76E0B78FF47AFF15D7D9DF956C1
X-CSE-ConnectionGUID: I0Ol1ECLTCy+Ghejv1D3Gw==
X-CSE-MsgGUID: MEFNGpquTUO2bDHZyrey1g==
Authentication-Results: mta.sm.ee; spf=Pass smtp.mailfrom=EVD.Admin@ecdc.europa.eu; spf=Pass smtp.helo=postmaster@EUR03-VI1-obe.outbound.protection.outlook.com; dkim=pass (signature verified) header.i=@ecdc.europa.eu; dmarc=pass (p=quarantine dis=none) d=ecdc.europa.eu
X-IPAS-Result: =?us-ascii?q?A0EjAAC8r9JngUtnayhaDg8BAQEBCQESAQUFAYF/CAELA?=
 =?us-ascii?q?YFAMVJiG1syBwhIhFaDTAOETl+IdZd0hE2BVhSBLD4PAQEBAQEBAQEBBwI9B?=
 =?us-ascii?q?wQBAQMEhDpGAhaLBiAGATQJDgECAQIBAQEBAQMCAwEBAQEBAQEBAQEBCwEBA?=
 =?us-ascii?q?QQBAQECAQECBAQBAgIQAQE7Bw47hXsNhAdlCTgBAQEBAQEBAQEBAQEBAQEBA?=
 =?us-ascii?q?QEBFgKBDRYRChMBAREBFQEPAREBRwMCBC8UEgEEAQ0FCBqCYYIcSAQCDqJXA?=
 =?us-ascii?q?YFAAgKLI4EygQGCDAEBBgQDAQPbWD2BZQMGgUgBhWyCYwEqgTMCDoQ6g0F7N?=
 =?us-ascii?q?oFVRCZvQoFmhCEBgScFARIBIysJgyU6gi+BFIEfgTt9gm+GNxKCLIRTiHmDO?=
 =?us-ascii?q?YVIgTKIYoFHIgMmMywBVRMXCwcFgTkzAyAKNBUcAhQdDwYQBGp6N4IMaUk6A?=
 =?us-ascii?q?g0CNYIbJFiCK4RNhDyEQYI/T4JAgTlYcYpFhGEtVDsdQAMLGyExPTcGDhsFB?=
 =?us-ascii?q?IE1oFR1ATqEboEQCiZvj26EbiUJboF0Sa8LNAeEHoFjDI0Bi1aHOBeEA02MP?=
 =?us-ascii?q?JlLmH4igjZAoGSFDQIEAgQFAg8BAQaBZzpsXQwHTSaDNAlGAxkPVo1LIwEUh?=
 =?us-ascii?q?EOOMwkBuQZENAI6AgcBCgEBAwmGSIsfAQE?=
X-Talos-CUID: 9a23:J1KqLW1rj1yo75JJQqiePrxfO5gCdiTw51PsCF77JmZkSqPMZQS/5/Yx
X-Talos-MUID: =?us-ascii?q?9a23=3AR06PTQ6gIxpyWk3JSLL7Pao9xoxNzoqIJ1gUjKk?=
 =?us-ascii?q?7nJOOGQxCKi2QnW24F9o=3D?=
X-IronPort-Anti-Spam-Filtered: true
X-IronPort-AV: E=Sophos;i="6.14,244,1736805600"; 
   d="scan'208,217";a="19565354"
X-MGA-submission: =?us-ascii?q?MDG+HRa0ZjsCftXbCxtgYvBMpt6xK63Iixole0?=
 =?us-ascii?q?iNA4u6renRCxxK7ABw6YvyJEGaXE8aujrpPsAVLATTe1JJbjT9hYSR7t?=
 =?us-ascii?q?syUe5OWqah0Cnd2nOsc2JxAS6KhIBFCvivBwfGgqIfdCzW+TwKAeqILA?=
 =?us-ascii?q?EQ?=
X-MS-Exchange-Organization-Network-Message-Id: 88171b22-8af2-4573-7d0f-08dd6217c9c9
X-MS-Exchange-Organization-AVStamp-Enterprise: 1.0
X-MS-Exchange-Organization-AuthSource: TEHIK-EX02.sotsiaalministeerium.ee
X-MS-Exchange-Organization-AuthAs: Anonymous
X-MS-Exchange-Transport-EndToEndLatency: 00:00:01.2153953
X-MS-Exchange-Processed-By-BccFoldering: 15.01.2507.044
X-MS-Has-Attach: 
X-MS-TNEF-Correlator: 
x-ms-publictraffictype: Email
x-ms-traffictypediagnostic: AM0P195MB0532:EE_|DB9P195MB2085:EE_
x-ms-office365-filtering-correlation-id: 7c772231-a1f8-42f1-95f2-08dd6217b5c9
x-ms-exchange-senderadcheck: 1
x-ms-exchange-antispam-relay: 0
x-microsoft-antispam: BCL:0;ARA:13230040|1800799024|376014|7416014|366016|921020|8096899003|38070700018;
x-microsoft-antispam-message-info: =?utf-8?B?ZUVFUllOUEdvL2JhMHh5SVh0OGFQdWpOSHZjZjJlZE5PdHVSeTFFbzVFVUlv?=
 =?utf-8?B?SHF6L3h0RVF4VTZmTytjY1NtQXJlSEl3M2pxU0FsNmZaMDc1dE9yeHdlL1JK?=
 =?utf-8?B?NkJ0N1pjTE0zaVk4YnRYZk5NRTBPK0pTTnNIVit6Y0YrR2hEUkRWNWM1RVFG?=
 =?utf-8?B?U20wejNWQkc3M0NBTFdQMVU0bWYxenBMTUVSYk5KSWFyazU0ZkphZmhxaTIr?=
 =?utf-8?B?TGRtcDFFNlEvRklmalVxZEhjNHM5b3ZNQWdBTVVGZGFnRm5xcFNWc0VqMUYy?=
 =?utf-8?B?TE9KSWg2aWpMbnVudmRuQXFlUTROYzlRRjF1U0lPakkxNTJEN0NUTHJ2MGV1?=
 =?utf-8?B?cGdKaEhBQ1V0UFcxbEc5VUc1RzNaUzNHQjFPRUplNG1SOWVrTm96dnJ1bXJ1?=
 =?utf-8?B?TTQxTjlhUkxjb0RvSzBnZWhIZVNSelVFSm5ST1RyQmNZSHRpY0M3bmRmci9z?=
 =?utf-8?B?enVDQ0RlZ0FOQ0ljSVpZS1FqbFcyUlUwZWQ5bTI5ZVVyTXVOUi9yMkN2eUhZ?=
 =?utf-8?B?OUFUZ1ZKaG1DOTQvZHlsczVOU3VQMU14WmlHZ1FUSjBiSlRWZnp6ZGIvaXVs?=
 =?utf-8?B?YVY4cXhsRFFsVUtoVk51OUJWUW1IdSt2bVBzbkN3eitkYU41TFlDM0F4RUVy?=
 =?utf-8?B?ZG1WcUR5N04yeGtXaVZ0dHdCSTRVVUMzUGo1R1l1T1RPQ1h6andnNjJkRWN6?=
 =?utf-8?B?eU1BQU9LeTV2cjRwWUJ1MXBRZlo0VkFVRlV1SDBDcThWTHZXVUROU3B0RFpn?=
 =?utf-8?B?djZhdnQzMm1wdGR
	JODFHT3R4aGRkaDBYc2srM20vOHc3OEh4akZab28xUDhr?=
 =?utf-8?B?bXlzVVRmalREcHYzb0JuK0JwNDArYWxjY0Q4WkhxOGhIbktIc21ENnNkODNG?=
 =?utf-8?B?ZTJ0cUdXWTdUZVl6N0ZUdngyL1FwelJpRkllL0hpZk9JYmFWanlhMHluYWdq?=
 =?utf-8?B?OXdUR1g3WHhlaEd5dzVJVXQ2MWpVbk81MGROVTBpMWF5YmVQM294SFhjRFRv?=
 =?utf-8?B?MUpMejVmWFU4Q0JPbDFZbzRKdHFKcFhDUWVxRVF2MXFoYkM2blZjRGQ5WlVv?=
 =?utf-8?B?UmhtWDhhRDFnMGlPMlk3VTZHa0o3T2FGZHFCNWp4Z3ZkQ1haRjZNWUxSK0J2?=
 =?utf-8?B?d1pzb2cySVRyY080c0g2NHJtNnJLb0FTeXlPRDdHUERWdERuK2ozUSs0ZDJa?=
 =?utf-8?B?SGJzcUhQVVJ6QnpTeENLTFZzeUs2ai91V3U3Vk8rT3ArazFTbnBhaFhEUSs1?=
 =?utf-8?B?RDNRQmUvMDhhWkhrNjFrNkZGQW9HTWtpRFd6UmFGdllNYWxPSVlUbXVhcW1r?=
 =?utf-8?B?bVQrTlBlaEFKeUFSWlBDS1QyU2ZzODc2SzlIbTd2M2tWVnNqbTZERWNPTzh4?=
 =?utf-8?B?b2xLSEZBcm9xaXJibzdMdGNaNGd2bzIrVVdWUWV6YzN0SUtXOWxLRk9HbGhE?=
 =?utf-8?B?Ynp0ZnJvSnl1b2YzcmxGMjRkTld6b0U0K2NBZEJGb3ZkblprL2NkOWwxS3dx?=
 =?utf-8?B?cUp4VFowMzZrbnAwRkRHeUZjRmtiVFFLczJOMDh1YVZsVnVvNEJBQ1crOHZF?=
 =?utf-8?B?d084SUxvZGdYenZ3TjI3MDRpVGlFN0JqZDVwVXpo
	UGpwQU5ObldCU1ZSK1cw?=
 =?utf-8?B?YzlLWkNBTzByRERRMW4xQXRIQWpWNjNWdFI0UUxVM3MrYUN4OGJ2RGhUaUdr?=
 =?utf-8?B?STJ2SVpZaXRabHpKNUFxQVJtMjlhN2tqaGdBRjk2R3JWLzFVcXpBWHFZUlJj?=
 =?utf-8?B?c2hYSVRBSFN0aDNJZGZTRVJOc0VqZVRXODVaRHc3dlUvL3VkSlpYQ1ptVVA5?=
 =?utf-8?B?Z1RqU2tlODBHWlc0TGJtMFMxY0JkV1RPUGh0K0hMVll5U1JKR0dRSEN3UWZi?=
 =?utf-8?B?TGNHSkFScGZQV1FubDRuc0xUSE1OZkxvU1hHQWw1Wk1WM1E9PQ==?=
x-forefront-antispam-report: CIP:255.255.255.255;CTRY:;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:AM0P195MB0532.EURP195.PROD.OUTLOOK.COM;PTR:;CAT:NONE;SFS:(13230040)(1800799024)(376014)(7416014)(366016)(921020)(8096899003)(38070700018);DIR:OUT;SFP:1101;
x-ms-exchange-antispam-messagedata-chunkcount: 1
x-ms-exchange-antispam-messagedata-0: =?utf-8?B?TmZLaHAxVGp3R1lvUDRWTUJEMjlJUGVtZTdueDlGM3V2SVhrSWU4d2lXa2xD?=
 =?utf-8?B?Z2lUWEJ0RWlsenFqRnNuSjRzaVdQQjA0Y3ZyYk9zZjV1Zmlta0xXOEVKNUU5?=
 =?utf-8?B?bWdlM1kwU1krOHJtblpqZ2l1TVpUY2FzcE0rZEhHOWRZQTA1REVaaXNUY1lr?=
 =?utf-8?B?RDdqM3RLenQ0aDNHcE1KOWV2eDF1dk5vdTJsOVIvZlVaL1VnOE0yRGZ3M044?=
 =?utf-8?B?UjEyNnpvSCs5SFQ4NCtYYUJ4eUUyekRlWWxzenJkRHJsMG9Wd2pvRDgwbzlS?=
 =?utf-8?B?bzVUQWNackVVeWZkeFQvMzlIcEFnNEhJdndtTTdrQ1E0NWpuMzdPMXp5Z1ky?=
 =?utf-8?B?NUV5MGtyZkFuY2NzTFZycXhzM2ZPeGNrQ1lxd2UrSXhCS2ppOVVTWTlCVUY4?=
 =?utf-8?B?WisxY29CWlNjRU03c05JTHA2NjlxM1RzYnFpTHFYY3hOSEQ1VkZTUEIxT2wz?=
 =?utf-8?B?S1VzREE2a1B1ZXN2VkttNmV6VjZJTDNJR0xXallGZzdEODNld0EvKzhtQTho?=
 =?utf-8?B?UmpTeVNBUHRlcHo1V2ltWHN5aUx0N21GSUZKUGcxbTN2b1JwUTE1WmpxZ01O?=
 =?utf-8?B?eE91YlUwR1UrRzErVGlWQnBSOEwzSE12aUlZZ3lrMFFQcHp4b2ZLY0cza0VV?=
 =?utf-8?B?Rmh1anNaTHIwZFhsUmYyVFQwQ013QjBJRWJmTGhlS2RxMGhKOTNhb2JNb0xO?=
 =?utf-8?B?YzlmYXJBUm5EQTU0YlhQZG11b3pXblFkeWtrZHhxZEVrSEJCWi9LaGRKSXll?=
 =?utf-8?B?bGp5NmFQbERqNmQ
	0Ly95UHdianJQUGtNeStqaHR4Z0piSUttTzd0aFQ4Z3Nq?=
 =?utf-8?B?c2hZK21ya0M4RU9OUzQ1UlMvRkVwNnFpWSttdG4vMmlFTWQxbXRzVTNwVmQx?=
 =?utf-8?B?VjBibHdKRVBONHBUdVN4MWNtTkNwWk8rVmR6ckYxVWYrQ1FCYjkzVzQzSkR1?=
 =?utf-8?B?L1UvR3FkK0kzbkx2R0djMXREUVNLN1NCdkwwY2hvOERPSXlGWnBHdEhQUmpi?=
 =?utf-8?B?QzQ5SWFlQk00dE5qRldZZTFaMm9hUG1IN055QjJwSlhuUEo1ZVVKRFJtSk1w?=
 =?utf-8?B?V2Y4V1V5OVJBaTFjS0d6a1d3MEdRVlJjVkVSVkhnSm5ycUIzdkZVYmNrNVJ3?=
 =?utf-8?B?cU9WejlrN0JDUmRuUmJTTUtYeHpxTHg4d2pJOU40Tk9TQ3MvOXEvV256dEJS?=
 =?utf-8?B?TzFwRDBsdnlrVnJRMDF1WG9Na2lINjRRL3cwQmFFTnh5UkxrWWl6aUgxdTVx?=
 =?utf-8?B?bW12cTR4b3pYTnFMa3ZmRmtkeHNVcEZxblBWeFRMZEU4M3duVVA4VkFzSG5k?=
 =?utf-8?B?SndzSzBGZVhPY0NlZk45WUVlNnRJekhhUDBTZHQ4RnZWNEFtNDBCWEM4M1NW?=
 =?utf-8?B?TVNrWStQRXVlbXNneDJVdlB0T20wVGRRYWhuM1VXd2tFSTVvWmlWaXRyeTJR?=
 =?utf-8?B?ZGtFVW9PWmZUdUFZVUR4Z1o2a0NqMVN4RGsra214SzFKQ2hidlgyZ0N5YW50?=
 =?utf-8?B?QmhDMnFsT0R6aFlZSUJ4RW05NWlEYUVzYVpreE9rVE5VYkhYdE9pUzhrdkl2?=
 =?utf-8?B?V1ZJa2QwSnBURGs2MGljWGRkY1A0ajZka3FHRjJz
	MFdmenVLcW1yUHdWbkR5?=
 =?utf-8?B?a3B4NHdTM1I2R2FPOTRLdGRjNEcvNHB0U3JtSng4RTNaSFE0YjFTSHgxeGYy?=
 =?utf-8?B?NTRjOFAyMTNwRUpZM2h1RXlCU0RzeVl0TzFTb0UyS0pTLzJQWDlaclVuclho?=
 =?utf-8?B?dDAwTC9OZ3pIYzJCVTQxOWo1UFBQTit4RnZFUGdFek1PTzJQZW9xeE13bHZ6?=
 =?utf-8?B?cnlxT0FDbmpsRFdIeXhyZ0xqblZkUEtyUkZrTzZJaGJTY2NJdFV5dmdtL1d0?=
 =?utf-8?B?OG5OeWZCQmdKUzVVaUEvbUZ3L00waVZIajZmbW04ZnlURTRzTEFudU5lcUFy?=
 =?utf-8?B?Nmw4ckJXWlI1Q3lRS0pNQjhtRWJuSUhVd2pZSmNLQjR1VDk0M0JqZmFKeFFF?=
 =?utf-8?B?QVNvbGF6RVR5REcrdzVQSDNYMUc1Q0lNQXExamZZODlKY0Y0M2I2TTN3WFlY?=
 =?utf-8?B?d1g3NGZJcjNxSGtiT2sxc1JhL205UDZ5Z0RWckFySnM3NnVHY3pybW5TMDVx?=
 =?utf-8?Q?O2Nm+JfAHz2kY2SsmYN5R6TS4?=
X-MS-Exchange-CrossTenant-AuthAs: Internal
X-MS-Exchange-CrossTenant-AuthSource: AM0P195MB0532.EURP195.PROD.OUTLOOK.COM
X-MS-Exchange-CrossTenant-Network-Message-Id: 7c772231-a1f8-42f1-95f2-08dd6217b5c9
X-MS-Exchange-CrossTenant-originalarrivaltime: 13 Mar 2025 10:13:32.9861
 (UTC)
X-MS-Exchange-CrossTenant-fromentityheader: Hosted
X-MS-Exchange-CrossTenant-id: 6ad73702-409c-4046-ae59-cc4bea334507
X-MS-Exchange-CrossTenant-mailboxtype: HOSTED
X-MS-Exchange-CrossTenant-userprincipalname: Vg+DkApT5jHVnSBpT0Z6MgsTVnUAY4I4jMbcyMU0mgRPkr0GY+BOfgMpZ9X2I3HKe5u5BOvcTnHD0UPw8osZKVzyd5EX5RKzIRZiZlm79EU=
X-MS-Exchange-Transport-CrossTenantHeadersStamped: DB9P195MB2085
x-ld-processed: 6ad73702-409c-4046-ae59-cc4bea334507,ExtAddr

This is a multipart message in MIME format.

------=_NextPart_000_00D8_01DB9413.EB509D60
Content-Type: text/plain;
	charset="UTF-8"
Content-Transfer-Encoding: 8bit


Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu 
saatja korral palume linke ja faile mitte avada.




To: National Focal Points for Emerging and vector-borne diseases - members 
and alternates; Operational Contact Points for Emerging and vector-borne 
diseases – epidemiology and microbiology.

Cc: National Coordinators





Dear colleagues,



We are pleased to announce that ECDC has recently updated the webpages on 
travel-associated cases of malaria, dengue, chikungunya, and Zika virus 
disease for the years 2019-2023.

These pages present the locations where travel-associated cases reported to 
ECDC were likely infected, providing valuable information for public health 
authorities and EU/EEA citizens regarding travel-related risks.

The latest update now also includes infection rates among travellers for 
2023.



Please find the links to the pages below:



Dengue: 
<https://www.ecdc.europa.eu/en/dengue/surveillance/dengue-virus-infections-travellers> 
Travel-associated dengue cases: place of infection of cases imported to the 
EU/EEA (europa.eu)

Malaria: 
<https://www.ecdc.europa.eu/en/infectious-disease-topics/malaria/surveillance-and-disease-data/travel-associated-malaria-cases> 
Travel-associated malaria cases: place of infection for cases imported to 
the European Union/European Economic Area (europa.eu)

Chikungunya: 
<https://www.ecdc.europa.eu/en/chikungunya-virus-disease/surveillance/travel-associated-cases> 
Travel-associated chikungunya cases: place of infection for cases imported 
into the EU/EEA (europa.eu)

Zika virus disease: 
<https://www.ecdc.europa.eu/en/zika-virus-infection/surveillance-and-disease-data/travel-associated-cases> 
Travel-associated Zika virus disease cases: place of infection of cases 
imported to the EU/EEA (europa.eu)



These webpages will be updated annually. We plan to incorporate the 2024 
data by the end of this year.



As always, your suggestions and feedback on these updates are welcomed by 
email to  <mailto:EVD.Outbreak@ecdc.europa.eu> EVD.Outbreak@ecdc.europa.eu.



Best regards,



The EVD team at ECDC




Confidentiality Notice
If you are not the intended recipient of this message, you are hereby kindly 
requested, to, consecutively, refrain from disclosing its content to any 
third party, delete it and inform its sender of the erroneous transmittal.


Classified as ECDC NORMAL 



------=_NextPart_000_00D8_01DB9413.EB509D60
Content-Type: text/html;
	boundary="_000_AM0P195MB0532698770D8392F685D86E1C1D32AM0P195MB0532EURP_";
	charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

<html xmlns:v=3D"urn:schemas-microsoft-com:vml" =
xmlns:o=3D"urn:schemas-microsoft-com:office:office" =
xmlns:w=3D"urn:schemas-microsoft-com:office:word" =
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" =
xmlns=3D"http://www.w3.org/TR/REC-html40"><head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; =
charset=3Dutf-8">
<meta name=3D"Generator" content=3D"Microsoft Word 15 (filtered =
medium)">
<style><!--
/* Font Definitions */
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Aptos;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0cm;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	mso-ligatures:standardcontextual;
	mso-fareast-language:EN-US;}
span.EmailStyle17
	{mso-style-type:personal-compose;
	font-family:"Aptos",sans-serif;
	color:windowtext;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-fareast-language:EN-US;}
@page WordSection1
	{size:612.0pt 792.0pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
	{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext=3D"edit" spidmax=3D"1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext=3D"edit">
<o:idmap v:ext=3D"edit" data=3D"1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang=3D"EN-GB" link=3D"#467886" vlink=3D"#96607D" =
style=3D"word-wrap:break-word"><table class=3D"MsoNormalTable" =
border=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"left" =
style=3D"mso-cellspacing:0cm;mso-yfti-tbllook:1184;mso-table-lspace:2.25p=
t;
 =
mso-table-rspace:2.25pt;mso-table-anchor-vertical:paragraph;mso-table-anc=
hor-horizontal:
 column;mso-table-left:left;mso-padding-alt:0cm 0cm 0cm 0cm">
 <tbody><tr =
style=3D"mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes">
 <td width=3D"100%" =
style=3D"width:100.0%;background:#FFE599;padding:5.25pt 3.75pt 5.25pt =
11.25pt">
 <p =
style=3D"mso-element:frame;mso-element-frame-hspace:2.25pt;mso-element-wr=
ap:
 =
around;mso-element-anchor-vertical:paragraph;mso-element-anchor-horizonta=
l:
 column;mso-height-rule:exactly"><strong><span =
style=3D"font-family:&quot;Arial&quot;,sans-serif;
 color:#212121">T=C3=A4helepanu!</span></strong><span =
style=3D"font-family:&quot;Arial&quot;,sans-serif;
 color:#212121"> Tegemist on v=C3=A4ljastpoolt asutust saabunud kirjaga. =
Tundmatu
 saatja korral palume linke ja faile mitte avada. </span><o:p></o:p></p>
 </td>
 </tr>
</tbody></table><br><span>&nbsp;</span>
<div class=3D"WordSection1">
<p class=3D"MsoNormal"><a name=3D"_Hlk161390219"><b><i><span =
style=3D"font-size:11.0pt">To:</span></i></b></a><span =
style=3D"mso-bookmark:_Hlk161390219"><i><span =
style=3D"font-size:11.0pt"> National Focal Points for Emerging and =
vector-borne diseases - members and alternates;
 Operational Contact Points for Emerging and vector-borne diseases =
=E2=80=93 epidemiology and microbiology.
<o:p></o:p></span></i></span></p>
<p class=3D"MsoNormal"><span =
style=3D"mso-bookmark:_Hlk161390219"><b><i><span =
style=3D"font-size:11.0pt">Cc:</span></i></b></span><span =
style=3D"mso-bookmark:_Hlk161390219"><i><span =
style=3D"font-size:11.0pt"> National Coordinators</span></i></span><span =
style=3D"mso-bookmark:_Hlk161390219"></span><span =
style=3D"font-size:11.0pt"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><b><span =
style=3D"font-size:11.0pt"><o:p>&nbsp;</o:p></span></b></p>
<p class=3D"MsoNormal"><span =
style=3D"font-size:11.0pt"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt">Dear =
colleagues,&nbsp;</span><span lang=3D"DE" =
style=3D"font-size:11.0pt"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span =
style=3D"font-size:11.0pt">&nbsp;</span><span lang=3D"DE" =
style=3D"font-size:11.0pt"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt">We are pleased =
to announce that ECDC has recently updated the webpages on =
travel-associated cases of malaria, dengue, chikungunya, and Zika virus =
disease for the years 2019-2023.
<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt">These pages =
present the locations where travel-associated cases reported to ECDC =
were likely infected, providing valuable information for public health =
authorities and EU/EEA citizens regarding travel-related
 risks. <o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt">The latest =
update now also includes infection rates among travellers for =
2023.<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span =
style=3D"font-size:11.0pt"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt">Please find the =
links to the pages below:&nbsp;</span><span lang=3D"DE" =
style=3D"font-size:11.0pt"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span =
style=3D"font-size:11.0pt"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt">Dengue: <a =
href=3D"https://www.ecdc.europa.eu/en/dengue/surveillance/dengue-virus-in=
fections-travellers" target=3D"_blank">
<span style=3D"color:#467886">Travel-associated dengue cases: place of =
infection of cases imported to the EU/EEA =
(europa.eu)</span></a>&nbsp;</span><span lang=3D"DE" =
style=3D"font-size:11.0pt"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt">Malaria: <a =
href=3D"https://www.ecdc.europa.eu/en/infectious-disease-topics/malaria/s=
urveillance-and-disease-data/travel-associated-malaria-cases" =
target=3D"_blank">
<span style=3D"color:#467886">Travel-associated malaria cases: place of =
infection for cases imported to the European Union/European Economic =
Area (europa.eu)</span></a>&nbsp;</span><span lang=3D"DE" =
style=3D"font-size:11.0pt"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt">Chikungunya: <a =
href=3D"https://www.ecdc.europa.eu/en/chikungunya-virus-disease/surveilla=
nce/travel-associated-cases" target=3D"_blank">
<span style=3D"color:#467886">Travel-associated chikungunya cases: place =
of infection for cases imported into the EU/EEA =
(europa.eu)</span></a>&nbsp;</span><span lang=3D"DE" =
style=3D"font-size:11.0pt"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt">Zika virus =
disease: <a =
href=3D"https://www.ecdc.europa.eu/en/zika-virus-infection/surveillance-a=
nd-disease-data/travel-associated-cases" target=3D"_blank">
<span style=3D"color:#467886">Travel-associated Zika virus disease =
cases: place of infection of cases imported to the EU/EEA =
(europa.eu)</span></a>&nbsp;</span><span lang=3D"DE" =
style=3D"font-size:11.0pt"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span =
style=3D"font-size:11.0pt">&nbsp;</span><span lang=3D"DE" =
style=3D"font-size:11.0pt"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt">These webpages =
will be updated annually. We plan to incorporate the 2024 data by the =
end of this year.
<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span =
style=3D"font-size:11.0pt"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt">As always, your =
suggestions and feedback on these updates are welcomed by email to
<a href=3D"mailto:EVD.Outbreak@ecdc.europa.eu"><span =
style=3D"color:#467886">EVD.Outbreak@ecdc.europa.eu</span></a>.<o:p></o:p=
></span></p>
<p class=3D"MsoNormal"><span =
style=3D"font-size:11.0pt"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt">Best =
regards,<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span =
style=3D"font-size:11.0pt"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><span style=3D"font-size:11.0pt">The EVD team at =
ECDC<o:p></o:p></span></p>
<p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p>
</div>
<p><br>
Confidentiality Notice<br>
If you are not the intended recipient of this message, you are hereby =
kindly requested, to, consecutively, refrain from disclosing its content =
to any third party, delete it and inform its sender of the erroneous =
transmittal.</p>
<br>
<p =
style=3D"font-family:Calibri;font-size:10pt;color:#000000;margin:5pt;font=
-style:normal;font-weight:normal;text-decoration:none;" =
align=3D"Center">
Classified as ECDC NORMAL=E2=80=AF<br>
</p>
</body>
</html>

------=_NextPart_000_00D8_01DB9413.EB509D60--
